These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8894209)

  • 1. Attention deficit disorder.
    Weaver A
    Br J Psychiatry; 1996 Oct; 169(4):523. PubMed ID: 8894209
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
    Rice T; Coffey B
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy.
    Kotcher L; Wieland N; Coffey B
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):137-41. PubMed ID: 17343563
    [No Abstract]   [Full Text] [Related]  

  • 5. Tics and Tourette syndrome.
    Shaw ZA; Coffey BJ
    Psychiatr Clin North Am; 2014 Sep; 37(3):269-86. PubMed ID: 25150562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
    Pringsheim T
    J Psychiatry Neurosci; 2012 Nov; 37(6):432. PubMed ID: 23092593
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.
    Kawabe K; Horiuchi F; Ueno SI
    Psychiatry Clin Neurosci; 2019 Dec; 73(12):762-763. PubMed ID: 31588606
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical management of Tourette's syndrome and associated disorders.
    Sandor P
    Can J Psychiatry; 1995 Dec; 40(10):577-83. PubMed ID: 8681254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacotherapy of Attention Deficit-Hyperactivity Disorder in Children with Comorbid Conditions.
    Naguy A
    Pediatr Neurol; 2018 May; 82():7-12. PubMed ID: 29678368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for clonidine in child psychiatry].
    Dollfus S
    Encephale; 1993; 19(2):83-7. PubMed ID: 8275901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
    Steingard R; Biederman J; Spencer T; Wilens T; Gonzalez A
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):350-3. PubMed ID: 8444764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity?
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Acta Paediatr; 2010 Dec; 99(12):1894-6. PubMed ID: 21355881
    [No Abstract]   [Full Text] [Related]  

  • 13. Self-, parent-, and teacher-reported behavioral symptoms in youngsters with Tourette syndrome: a case-control study.
    Cardona F; Baglioni V; Silvestri PR; Chiarotti F
    Eur J Paediatr Neurol; 2012 Mar; 16(2):213-4. PubMed ID: 21703890
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Rowles BM; Findling RL
    Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tourette syndrome: an analysis of its comorbidity and specific treatment].
    Castellanos FX; Acosta MT
    Rev Neurol; 2004 Feb; 38 Suppl 1():S124-30. PubMed ID: 15011166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
    Naguy A
    J Nerv Ment Dis; 2017 Sep; 205(9):738. PubMed ID: 28846573
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric clonidine poisoning as a result of pharmacy compounding error.
    Suchard JR; Graeme KA
    Pediatr Emerg Care; 2002 Aug; 18(4):295-6. PubMed ID: 12187137
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonidine and stuttering.
    Vink HJ; Althaus M; Goorhuis-Brouwer SM; Minderaa RB
    Am J Psychiatry; 1992 May; 149(5):717-8. PubMed ID: 1575277
    [No Abstract]   [Full Text] [Related]  

  • 19. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
    Robertson MM
    Eur Child Adolesc Psychiatry; 2006 Feb; 15(1):1-11. PubMed ID: 16514504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep disorders in children with Tourette syndrome.
    Ghosh D; Rajan PV; Das D; Datta P; Rothner AD; Erenberg G
    Pediatr Neurol; 2014 Jul; 51(1):31-5. PubMed ID: 24938137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.